| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Animal Models |
From the Department of Medicine B* and the Institute of Pathology, Münster University Hospital, Münster, Germany; Biogen Incorporated, Cambridge, Massachusetts; the Center for Neurologic Diseases,¶ Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts; and the Department of Medicine, Section of Clinical Immunology, Zürich University Hospital, Zürich, Switzerland
Abstract
Inflammatory bowel disease is associated with immune activation in Peyer’s patches and mucosal lymph nodes. The role of these organs in dextran sodium sulfate (DSS)-induced colitis was investigated. We used mice lacking Peyer’s patches and/or lymph nodes because of lymphotoxin-
gene deficiency or treatment in utero with lymphotoxin-ß-receptor IgG and tumor necrosis factor-receptor-I (55)-IgG fusion proteins. Mice lacking Peyer’s patches and lymph nodes because of lymphotoxin- deficiency or in utero fusion protein treatment developed more severe colitis than control mice as indicated by more severe intestinal shrinking, longer colonic ulcers, and higher histological disease scores. Oral DSS triggered the formation of colonic submucosal lymphoid patches in these mice and caused an increase in the number of submucosal lymphoid patches in mice treated in utero with the fusion proteins. Mice lacking Peyer’s patches only showed more submucosal lymphoid patches whereas intestinal length and histological disease score were similar to control mice. In conclusion, more severe DSS-induced colitis correlates with the loss of the mesenteric lymph nodes. However, neither the absence of Peyer’s patches nor the presence of colonic lymphoid patches were correlated with increased disease severity.
This article has been cited by other articles:
 |
|
 |
|
  N. E. Humphreys, D. Xu, M. R. Hepworth, F. Y. Liew, and R. K. Grencis IL-33, a Potent Inducer of Adaptive Immunity to Intestinal Nematodes J. Immunol., February 15, 2008; 180(4): 2443 - 2449. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. W SPAHN, M. K MULLER, W. DOMSCHKE, and T. KUCHARZIK Role of Lymphotoxins in the Development of Peyer's Patches and Mesenteric Lymph Nodes: Relevance to Intestinal Inflammation and Treatment. Ann. N.Y. Acad. Sci., August 1, 2006; 1072: 187 - 193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. GULLBERG and J. D SODERHOLM Peyer's Patches and M Cells as Potential Sites of the Inflammatory Onset in Crohn's Disease. Ann. N.Y. Acad. Sci., August 1, 2006; 1072: 218 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-N. Kweon, M. Yamamoto, P. D. Rennert, E. J. Park, A.-Y. Lee, S.-Y. Chang, T. Hiroi, M. Nanno, and H. Kiyono Prenatal Blockage of Lymphotoxin {beta} Receptor and TNF Receptor p55 Signaling Cascade Resulted in the Acceleration of Tissue Genesis for Isolated Lymphoid Follicles in the Large Intestine J. Immunol., April 1, 2005; 174(7): 4365 - 4372. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Eberl and D. R. Littman Thymic Origin of Intestinal {alpha}{beta} T Cells Revealed by Fate Mapping of ROR{gamma}t+ Cells Science, July 9, 2004; 305(5681): 248 - 251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Stopfer, D. N. Mannel, and T. Hehlgans Lymphotoxin-{beta} Receptor Activation by Activated T Cells Induces Cytokine Release from Mouse Bone Marrow-Derived Mast Cells J. Immunol., June 15, 2004; 172(12): 7459 - 7465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T W Spahn and T Kucharzik Modulating the intestinal immune system: the role of lymphotoxin and GALT organs Gut, March 1, 2004; 53(3): 456 - 465. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
